Sort
261,768 grants matching “gene therapy”
AKI-Sapere- a novel prognostic of Acute Kidney Injury due to cardiac surgery
$893,202Natalia Mitin · Sapere Bio, Inc. · R44 · FY2020 · AG
Project 2 - Ex Vivo Analysis of Coronavirus Tropism, Adaptation, Replication, and Host Response
$893,131Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
Making hypomorphic tumor supressors in vivo using RNAi
$893,063Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2008 · CA
Design And Development Of Experimental Therapeutics
$893,041Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$892,889Mamta K Jain · Ut Southwestern Medical Center · U01 · FY2007 · AI
POLYCOMB REPRESSIVE COMLEXE AS KEY REGULATORS OF HIV LATENCY AND TARGETS FOR LATENCY REVERSAL
$892,816Lindsey Ingerman James · Univ Of North Carolina Chapel Hill · R61 · FY2018 · DA
Study of CAR T cells and mechanisms of resistance in pediatric brain tumors
$892,774Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
NV103: Antibody Conjugated Nanoparticle for Ewing Sarcoma Targeted Therapy
$892,769Jon O Nagy · Nanovalent Pharmaceuticals, Inc. · R44 · FY2020 · CA
Center of Excellence for Health Disparities Research: EI Centro
$892,728Victoria B Mitrani · University Of Miami Coral Gables · P60 · FY2015 · MD
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$892,711Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2022 · CA
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$892,711Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2023 · CA
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$892,711Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2021 · CA
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus
$892,710Gordon H Williams · Brigham And Women'S Hospital · R01 · FY2010 · HL
Hypertension Pharmacogenetics
$892,652University Of Florida · R01 · FY2003 · HL
Towards Curative Therapies for Hypogonadotropic Diseases
$892,586Stephanie Seminara · Massachusetts General Hospital · R37 · FY2025 · HD
Transcriptional condensates, epigenetic editing and Rett Syndrome
$892,575Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2022 · MH
The effect of cytomegalovirus, inflammation, and immune activation on neurodevelopment in children exposed to maternal HIV infection
$892,566Jennifer Ann Slyker · University Of Washington · P01 · FY2022 · HD
DCTD Functional Genomics
$892,388David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Prevention of Relapse in Addiction
$892,307Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2017 · DA
Development of an intravenous CB1 antagonist for acute cannabinoid intoxication and cannabis hyperemesis syndrome
$892,290Kenneth Cundy · Anebulo Pharmaceuticals, Inc. · U01 · FY2024 · DA
Biophysical and molecular dialogue of glioma cells and the brain microenvironment
$892,238Gabriele Bergers · University Of California, San Francisco · U54 · FY2011 · CA
Genome-Wide Predictors of Treatment-Related Toxicities
$892,235Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
Combined cytokine therapy for sustained HIV remission
$892,227Vijayakumar Velu · Emory University · R01 · FY2024 · AI
A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
$892,209Gary Fanger · Rise Therapeutics, Llc · R44 · FY2020 · DK
PIWI proteins and PIWI-interacting small RNAs guard the genomic integrity of germ cells
$892,144Astrid Haase · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK